Octave Bioscience Names Jennifer Mellum Vice President of Marketing as Precision Neurology Platform Scales

▤ Summary

Octave Bioscience appointed Jennifer Mellum as Vice President of Marketing as the company scales its precision neurology platform. The company says it is seeing strong commercial growth and is expanding adoption of its MSDA Test for multiple sclerosis. Octave is also advancing a multi-analyte blood test for Parkinson’s disease with the Michael J. Fox Foundation. The hire strengthens its senior commercial team as it builds awareness, ordering experience, and strategic partnerships across the life sciences ecosystem.

▦ Linked Companies